Abbott (ABT) Reports In-Line Q4 Results, Offers Q1 and FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020
January 22, 2020 7:30 AM ESTABBOTT PARK, Ill., Jan. 22, 2020 /PRNewswire/ --Â Abbott (NYSE: ABT)Â today announced financial results for the fourth quarter and full year ended Dec. 31, 2019.
Fourth-quarter worldwide sales of $8.3 billion increased 7.1 percent on a reported basis and 8.5 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.59 in the fourth quarter. Adjusted diluted EPS from continuing operations, which excludes specified items, was $0.95, an increase of 17.3 percent versus prior year1. Abbott issues full-year 2020 guidance for organic sales growth of 7.0 to 8.0 percent2, which excludes the... More